• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Omicron BA.4/5 neutralization and cell-mediated immune responses in relation to baseline immune status and breakthrough infection amo

tetano

Editor, Senior Moderator
J Med Virol


. 2024 Feb;96(2):e29446.
doi: 10.1002/jmv.29446. Omicron BA.4/5 neutralization and cell-mediated immune responses in relation to baseline immune status and breakthrough infection among PLWH: A follow-up cohort study

Haoting Zhan[SUP] 1 [/SUP], Yuchen Xie[SUP] 2 3 [/SUP], Yongmei Liu[SUP] 1 [/SUP], Linlin Cheng[SUP] 1 [/SUP], Yi Xu[SUP] 3 [/SUP], Xiaojing Qu[SUP] 4 [/SUP], Chen Li[SUP] 4 [/SUP], Xinru Guo[SUP] 2 3 [/SUP], Haolong Li[SUP] 1 [/SUP], Yuling Wang[SUP] 4 [/SUP], Erhei Dai[SUP] 3 [/SUP], Lijing Wang[SUP] 4 [/SUP], Huixia Gao[SUP] 3 [/SUP], Yongzhe Li[SUP] 1 1 [/SUP]



Affiliations
Abstract

There is a paucity of data on hybrid immunity (vaccination plus breakthrough infection [BI]), especially cell-mediated responses to Omicron among immunosuppressed patients. We aim to investigate humoral and cellular responses to Omicron BA.4/5 among people living with HIV (PLWH) with/without BIs, the most prevalent variant of concern after the reopening of China. Based on our previous study, we enrolled 77 PLWH with baseline immune status of severe acute respiratory syndrome coronavirus 2 specific antibodies after inactivated vaccination. "Correlates of protection," including serological immunoassays, T cell phenotypes and memory B cells (MBC) were determined in PLWH without and with BI, together with 16 PLWH with reinfections. Higher inhibition rate of neutralizing antibodies (NAb) against BA.4/5 was elicited among PLWH with BI than those without. Omicron-reactive IL4[SUP]+[/SUP] CD8[SUP]+[/SUP] T cells were significantly elevated in PLWH experienced postvaccine infection contrasting with those did not. NAb towards wild type at baseline was associated with prolonged negative conversion time for PLWH whereas intermediate MBCs serve as protecting effectors. We uncovered that hybrid immunity intensified more protection on BA.4/5 than vaccination did. Strengthened surveillance on immunological parameters and timely clinical intervention on PLWH deficient in protection would reduce the severity and mortality in the context of coexistence with new Omicron subvariants.

Keywords: SARS-CoV-2; antibodies; breakthrough infection; cellular response; people living with HIV.

 
Back
Top Bottom